Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds LCI.
No tracked institution reports a position in LCI as of their last filing.
| Execution date | Ratio |
|---|---|
| 2023-02-07 | 1-for-4reverse |
| 2003-03-03 | 5-for-2 |
No one on the platform has traded LCI yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Beat consensus in 5 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2023-02-01 | $-1.64 | $-1.36 | +17.1% |
| 2022-11-02 | $-1.84 | $-1.68 | +8.7% |
| 2022-08-24 | $-1.84 | $-1.76 | +4.3% |
| 2022-05-04 | $-1.72 | $-1.64 | +4.7% |
| 2022-02-03 | $-1.28 | $-1.56 | -21.9% |
| 2021-11-03 | $-1.00 | $-1.08 | -8.0% |
| 2021-08-25 | $-0.32 | $-0.76 | -137.5% |
| 2021-05-05 | $-0.20 | $0.08 | +140.0% |
| $7M |
| — |
| MODVModivCare Inc. | $0.43 | +0.00% | $6M | — |
| NLTXNeoleukin Therapeutics, Inc. | $3.49 | +1.45% | $8M | — |
Source: Financial Modeling Prep · peers by sector/industry